Inclusion Criteria:  Diagnosis of CLL was according to the IWCLL criteria All patients received two 30-μg doses of BNT162b2, administered intramuscularly 3 weeks apart. (Pfizer).  Exclusion Criteria:  previous covid19 virus infection